Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Strainsforpains, Inc. (EBYH)

0.1630
0.0000
(0.00%)
At close: April 25 at 4:00:00 PM EDT
Loading Chart for EBYH
  • Previous Close 0.0000
  • Open 0.1630
  • Bid 0.1630 x --
  • Ask 0.1900 x --
  • Day's Range 0.1630 - 0.1630
  • 52 Week Range 0.0750 - 0.3700
  • Volume 2,049
  • Avg. Volume 422
  • Market Cap (intraday) 2.336M
  • Beta (5Y Monthly) 0.31
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Strainsforpains, Inc. operates as a medical marijuana data recommendation system. The company develops Strainsforpains app, a user-based application that scientifically determines which cannabis brand or strain is right for patients based upon personal data and strain genetics. It serves medical specialists, dispensaries, and consumers. Strainsforpains, Inc. has a strategic partnership with GenBio, Inc. to license anti-inflammatory compounds in Strainsforpains CBD branded products. The company was incorporated in 1990 and is based in New York, New York.

strainsforpains.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EBYH

View More

Performance Overview: EBYH

Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

EBYH
16.41%
S&P 500 (^GSPC)
6.06%

1-Year Return

EBYH
25.38%
S&P 500 (^GSPC)
9.44%

3-Year Return

EBYH
37.33%
S&P 500 (^GSPC)
28.61%

5-Year Return

EBYH
47.08%
S&P 500 (^GSPC)
94.77%

Compare To: EBYH

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EBYH

View More

Valuation Measures

Annual
As of 4/25/2025
  • Market Cap

    2.34M

  • Enterprise Value

    2.34M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -102.8k

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.29k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: EBYH

View More

Company Insights: EBYH

Research Reports: EBYH

View More

People Also Watch